These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 35960749)

  • 1. Triple-negative breast cancer influences a mixed M1/M2 macrophage phenotype associated with tumor aggressiveness.
    Pe KCS; Saetung R; Yodsurang V; Chaotham C; Suppipat K; Chanvorachote P; Tawinwung S
    PLoS One; 2022; 17(8):e0273044. PubMed ID: 35960749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Salvianolic Acid A on Tumor-Associated Macrophage Polarization and Its Mechanisms in the Tumor Microenvironment of Triple-Negative Breast Cancer.
    Tang C; Jiang ST; Li CX; Jia XF; Yang WL
    Molecules; 2024 Mar; 29(7):. PubMed ID: 38611749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated macrophages of the M1/M2 phenotype are involved in the regulation of malignant biological behavior of breast cancer cells through the EMT pathway.
    Chen Z; Wu J; Wang L; Zhao H; He J
    Med Oncol; 2022 May; 39(5):83. PubMed ID: 35570226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated macrophages promote epithelial-mesenchymal transition and the cancer stem cell properties in triple-negative breast cancer through CCL2/AKT/β-catenin signaling.
    Chen X; Yang M; Yin J; Li P; Zeng S; Zheng G; He Z; Liu H; Wang Q; Zhang F; Chen D
    Cell Commun Signal; 2022 Jun; 20(1):92. PubMed ID: 35715860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC.
    Bao X; Shi R; Zhao T; Wang Y; Anastasov N; Rosemann M; Fang W
    Cancer Immunol Immunother; 2021 Jan; 70(1):189-202. PubMed ID: 32681241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple negative breast cancer: Key role of Tumor-Associated Macrophages in regulating the activity of anti-PD-1/PD-L1 agents.
    Santoni M; Romagnoli E; Saladino T; Foghini L; Guarino S; Capponi M; Giannini M; Cognigni PD; Ferrara G; Battelli N
    Biochim Biophys Acta Rev Cancer; 2018 Jan; 1869(1):78-84. PubMed ID: 29126881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Genes Associated with Prognosis and Immunotherapy Prediction in Triple-Negative Breast Cancer via M1/M2 Macrophage Ratio.
    Liu J; Deng Y; Liu Z; Li X; Zhang M; Yu X; Liu T; Chen K; Li Z
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512096
    [No Abstract]   [Full Text] [Related]  

  • 9. The Streptococcus virulence protein PepO triggers anti-tumor immune responses by reprograming tumor-associated macrophages in a mouse triple negative breast cancer model.
    Liu B; Huang J; Xiao J; Xu W; Zhang H; Yuan Y; Yin Y; Zhang X
    Cell Biosci; 2023 Nov; 13(1):198. PubMed ID: 37925462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SILAC proteomics based on 3D cell spheroids unveils the role of RAC2 in regulating the crosstalk between triple-negative breast cancer cells and tumor-associated macrophages.
    Guo Y; Deng X; Wang S; Yuan Y; Guo Z; Hao H; Jiao Y; Li P; Han S
    Int J Biol Macromol; 2024 Jan; 254(Pt 1):127639. PubMed ID: 37879580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory Impact Of Cinobufagin In Triple-Negative Breast Cancer Metastasis: Involvements Of Macrophage Reprogramming Through Upregulated MME and Inactivated FAK/STAT3 Signaling.
    Zhu Z; Wang H; Qian X; Xue M; Sun A; Yin Y; Tang J; Zhang J
    Clin Breast Cancer; 2024 Jun; 24(4):e244-e257.e1. PubMed ID: 38378361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer.
    Weng YS; Tseng HY; Chen YA; Shen PC; Al Haq AT; Chen LM; Tung YC; Hsu HL
    Mol Cancer; 2019 Mar; 18(1):42. PubMed ID: 30885232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGFA/NRP-1/GAPVD1 axis promotes progression and cancer stemness of triple-negative breast cancer by enhancing tumor cell-macrophage crosstalk.
    Wang L; Zhang L; Zhao L; Shao S; Ning Q; Jing X; Zhang Y; Zhao F; Liu X; Gu S; Zhao X; Luo M
    Int J Biol Sci; 2024; 20(2):446-463. PubMed ID: 38169627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Immunosuppressive Microenvironment in BRCA1-IRIS-Overexpressing TNBC Tumors Is Induced by Bidirectional Interaction with Tumor-Associated Macrophages.
    Sami E; Paul BT; Koziol JA; ElShamy WM
    Cancer Res; 2020 Mar; 80(5):1102-1117. PubMed ID: 31911557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1 blockade TAM-dependently potentiates mild photothermal therapy against triple-negative breast cancer.
    Wang C; Xu YH; Xu HZ; Li K; Zhang Q; Shi L; Zhao L; Chen X
    J Nanobiotechnology; 2023 Dec; 21(1):476. PubMed ID: 38082443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress.
    Al Haq AT; Tseng HY; Chen LM; Wang CC; Hsu HL
    Cell Death Dis; 2022 Jan; 13(1):49. PubMed ID: 35017469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44v5 domain regulates crosstalk between TNBC cells and tumor-associated macrophages by enhancing the IL-4R/STAT3 axis.
    Dai Y; Ji Z; Liang H; Jiang M; Wang L; Bao X; Liu J; Liu M; Yang C
    Cancer Sci; 2024 Jul; 115(7):2235-2253. PubMed ID: 38700108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G6PD activation in TNBC cells induces macrophage recruitment and M2 polarization to promote tumor progression.
    Li Y; Han X; Lin Z; Wang C; Fu Z; Sun Q; Li C
    Cell Mol Life Sci; 2023 May; 80(6):165. PubMed ID: 37237244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes derived from rapamycin-treated 4T1 breast cancer cells induced polarization of macrophages to M1 phenotype.
    Ghalavand M; Moradi-Chaleshtori M; Dorostkar R; Mohammadi-Yeganeh S; Hashemi SM
    Biotechnol Appl Biochem; 2023 Oct; 70(5):1754-1771. PubMed ID: 37254633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AXL antibody and AXL-ADC mediate antitumor efficacy via targeting AXL in tumor-intrinsic epithelial-mesenchymal transition and tumor-associated M2-like macrophage.
    Pei JP; Wang Y; Ma LP; Wang X; Liu L; Zhang Y; Jin R; Ren ZQ; Deng Y; Shen JK; Meng T; Yu K
    Acta Pharmacol Sin; 2023 Jun; 44(6):1290-1303. PubMed ID: 36650292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.